Back to results
US 10,744,084 B2Granted
Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
AssigneesSquarex, LLC, BioVentures, LLC
InventorsHugh McTavish, Thomas Dag Horn, Sandra Marchese Johnson
Life of this patent
Estimating the term…
Abstract
A method is presented for treating herpes simplex virus (HSV) infection comprising: (a) locally administering a substance that induces a delayed type hypersensitivity (DTH) response to a patient at a site of an HSV lesion to induce a DTH response at the site of the lesion during one or more outbreaks of the HSV infection.
Claims8
A pharmaceutical composition consisting essentially of squaric acid dibutylester (SADBE) dissolved in dimethylsulfoxide (DMSO), wherein the SADBE is at a concentration in the composition of 0.05% to about 2% (wt./vol).
Dependencies are inferred from the claim text.